Literature DB >> 16838184

Long-term outcome 19 years after childhood IgA nephritis: a retrospective cohort study.

Jaana Ronkainen1, Marja Ala-Houhala, Helena Autio-Harmainen, Timo Jahnukainen, Olli Koskimies, Jussi Merenmies, Jukka Mustonen, Timo Ormälä, Juha Turtinen, Matti Nuutinen.   

Abstract

We evaluated the natural long-term outcome after childhood IgA nephritis. Altogether 55 patients with biopsy-proven IgA nephritis were identified, 37 (67%) responded to the health questionnaire and 31 (56%) participated in the medical examination after a mean follow-up of 18.7 years (SD 6.2; range 8.5-29.8). The results of medical examination, onset data and the re-analysis of original biopsies of 31 participants were used when analyzing the predictive factors for persistent nephropathy, i.e. constant proteinuria/hematuria or end-stage renal disease (ESRD). All patients' medical history data were obtained from regional hospitals and renal survival data from the national kidney register. Six (11%) of the 55 identified patients had developed ESRD. Sixteen (52%) of the 31 participants were not attending for regular follow-up visits after the acute phase. Twenty-two (71%) had renal symptoms and 12 (39%) were receiving drugs for hypertension/proteinuria at their latest follow-up visit. The chronicity index and total biopsy score in the first renal biopsy were higher in patients with persistent nephropathy or ESRD than in those without (p=0.022 and p=0.014, respectively). Nine (69%) of the 13 subjects who had been over 16 years of age at diagnosis had persistent nephropathy or ESRD, compared with 4 (22%) of the 18 subjects who had been under 16 years of age (relative risk 3.1, 95% CI 1.2-8.0). Pregnancy complications were common: 12 (55%) of the 22 pregnancies had been complicated by proteinuria and/or hypertension, and the prematurity rate was 30%. Long-term follow-up during adulthood is needed even after mild childhood IgA nephritis, especially in women during and after pregnancy.

Entities:  

Mesh:

Year:  2006        PMID: 16838184     DOI: 10.1007/s00467-006-0163-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  25 in total

1.  Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.

Authors:  Hyun Soon Lee; Myung Suk Lee; Sa Min Lee; Sang Yun Lee; Eun Sun Lee; Eun Young Lee; So Yeon Park; Jin Suk Han; Sungkwon Kim; Jung Sang Lee
Journal:  Nephrol Dial Transplant       Date:  2004-12-23       Impact factor: 5.992

Review 2.  Pathophysiology and treatment of IgA nephropathy in children.

Authors:  N Yoshikawa; R Tanaka; K Iijima
Journal:  Pediatr Nephrol       Date:  2001-05       Impact factor: 3.714

Review 3.  Henoch-Schönlein nephritis. A disease with significant late sequelae.

Authors:  R H White
Journal:  Nephron       Date:  1994       Impact factor: 2.847

4.  IgA nephropathy in Japanese children and adults: a comparative study of clinicopathological features.

Authors:  K Okada; M Funai; K Kawakami; S Kagami; I Yano; Y Kuroda
Journal:  Am J Nephrol       Date:  1990       Impact factor: 3.754

5.  IgA nephropathy: prognostic classification of end-stage renal failure. L'Association des Néphrologues de l'Est.

Authors:  L Frimat; S Briançon; D Hestin; B Aymard; E Renoult; T C Huu; M Kessler
Journal:  Nephrol Dial Transplant       Date:  1997-12       Impact factor: 5.992

6.  The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study.

Authors:  Jaana Ronkainen; Matti Nuutinen; Olli Koskimies
Journal:  Lancet       Date:  2002-08-31       Impact factor: 79.321

7.  Microscopic hematuria in school children: epidemiology and clinicopathologic evaluation.

Authors:  V M Vehaskari; J Rapola; O Koskimies; E Savilahti; J Vilska; N Hallman
Journal:  J Pediatr       Date:  1979-11       Impact factor: 4.406

8.  IgA nephropathy: long-term prognosis for pediatric patients.

Authors:  R J Wyatt; S B Kritchevsky; S Y Woodford; P M Miller; S Roy; N H Holland; E Jackson; N A Bishof
Journal:  J Pediatr       Date:  1995-12       Impact factor: 4.406

9.  Macroscopic hematuria in childhood IgA nephropathy.

Authors:  N Yoshikawa; H Ito; K Iijima; C Nakahara; K Maehara; O Hasegawa; S Okada; T Matsuo
Journal:  Clin Nephrol       Date:  1987-11       Impact factor: 0.975

Review 10.  Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: survey of the recent literature.

Authors:  G D'Amico
Journal:  Am J Kidney Dis       Date:  1992-10       Impact factor: 8.860

View more
  21 in total

1.  Renal survival in pediatric patients with IgA nephropathy.

Authors:  M Colleen Hastings; Noel M Delos Santos; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2006-09-21       Impact factor: 3.714

2.  The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch-Schönlein purpura nephritis.

Authors:  Mikael Koskela; Elisa Ylinen; Elli-Maija Ukonmaanaho; Helena Autio-Harmainen; Päivi Heikkilä; Jouko Lohi; Outi Jauhola; Jaana Ronkainen; Timo Jahnukainen; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2017-02-14       Impact factor: 3.714

3.  When should we consider renal biopsy in children with isolated microscopic hematuria?

Authors:  Se Jin Park; Ji Eun Kim; Jae Il Shin
Journal:  Clin Exp Nephrol       Date:  2014-03-25       Impact factor: 2.801

Review 4.  Biomarkers and targeted new therapies for IgA nephropathy.

Authors:  Rosanna Coppo
Journal:  Pediatr Nephrol       Date:  2016-06-20       Impact factor: 3.714

Review 5.  Pathogenesis of glomerular haematuria.

Authors:  Claudia Yuste; Eduardo Gutierrez; Angel Manuel Sevillano; Alfonso Rubio-Navarro; Juan Manuel Amaro-Villalobos; Alberto Ortiz; Jesus Egido; Manuel Praga; Juan Antonio Moreno
Journal:  World J Nephrol       Date:  2015-05-06

6.  Cyclosporine A vs. methylprednisolone for Henoch-Schönlein nephritis: a randomized trial.

Authors:  Outi Jauhola; Jaana Ronkainen; Helena Autio-Harmainen; Olli Koskimies; Marja Ala-Houhala; Pekka Arikoski; Tuula Hölttä; Timo Jahnukainen; Jukka Rajantie; Timo Ormälä; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2011-05-28       Impact factor: 3.714

7.  Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.

Authors:  Rosanna Coppo; Danilo Lofaro; Roberta R Camilla; Shubha Bellur; Daniel Cattran; H Terence Cook; Ian S D Roberts; Licia Peruzzi; Alessandro Amore; Francesco Emma; Laura Fuiano; Ulla Berg; Rezan Topaloglu; Yelda Bilginer; Loreto Gesualdo; Rosaria Polci; Malgorzata Mizerska-Wasiak; Yasar Caliskan; Sigrid Lundberg; Giovanni Cancarini; Colin Geddes; Jack Wetzels; Andrzej Wiecek; Magdalena Durlik; Stefano Cusinato; Cristiana Rollino; Milena Maggio; Manuel Praga; Hilde K Smerud; Vladimir Tesar; Dita Maixnerova; Jonathan Barratt; Teresa Papalia; Renzo Bonofiglio; Gianna Mazzucco; Costantinos Giannakakis; Magnus Soderberg; Diclehan Orhan; Anna Maria Di Palma; Jadwiga Maldyk; Yasemin Ozluk; Birgitta Sudelin; Regina Tardanico; David Kipgen; Eric Steenbergen; Henryk Karkoszka; Agnieszka Perkowska-Ptasinska; Franco Ferrario; Eduardo Gutierrez; Eva Honsova
Journal:  Pediatr Nephrol       Date:  2016-08-25       Impact factor: 3.714

Review 8.  Haematuria as a risk factor for chronic kidney disease progression in glomerular diseases: A review.

Authors:  Juan Antonio Moreno; Claudia Yuste; Eduardo Gutiérrez; Ángel M Sevillano; Alfonso Rubio-Navarro; Juan Manuel Amaro-Villalobos; Manuel Praga; Jesús Egido
Journal:  Pediatr Nephrol       Date:  2015-05-17       Impact factor: 3.714

Review 9.  Stage 1 chronic kidney disease in pregnancy.

Authors:  Tiina Podymow; Phyllis August
Journal:  Obstet Med       Date:  2012-09-17

Review 10.  New therapeutic perspectives for IgA nephropathy in children.

Authors:  Alexandra Cambier; Patrick J Gleeson; Héloise Flament; Marie-Bénédicte Le Stang; Renato C Monteiro
Journal:  Pediatr Nephrol       Date:  2020-02-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.